Kamau Therapeutics is a clinical-stage company developing a new class of therapies to cure a range of serious and life-threatening diseases.
Kamau Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Kamau Therapeutics is headquartered in South San Francisco, United States.
Kamau Therapeutics is a clinical-stage company developing a new class of therapies to cure a range of serious and life-threatening diseases.
Kamau Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kamau Therapeutics — Funding & Investors." VCBacked, June 3, 2025, https://www.vcbacked.co/company/kamau-therapeutics. Accessed August 7, 2026.
VCBacked. (2025). Kamau Therapeutics — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/kamau-therapeutics
{{cite web |title=Kamau Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kamau-therapeutics |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated